Stefano Gazzina Selected Research

Granulins

1/2022	An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers.
1/2022	Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia.
12/2021	Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study.
1/2017	Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation.
2/2016	White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations.
1/2016	Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials: A Multi-Voxel Pattern Analysis Study in Granulin Disease.
2/2014	Effect of TMEM106B polymorphism on functional network connectivity in asymptomatic GRN mutation carriers.
1/2014	Subcortical and Deep Cortical Atrophy in Frontotemporal Dementia due to Granulin Mutations.
7/2013	The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study.
7/2013	Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Gazzina Research Topics

Disease

8	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 01/2013
7	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020 - 01/2013
5	Atrophy 01/2022 - 07/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2016
2	COVID-19 01/2020 - 01/2020
1	Cognitive Dysfunction 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Myoclonic dystonia 01/2017
1	Hemochromatosis (Bronze Diabetes) 01/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016
1	Parkinsonian Disorders (Parkinsonism) 01/2014
1	Inflammation (Inflammations) 07/2013

Drug/Important Bio-Agent (IBA)

11	GranulinsIBA 01/2022 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	SteroidsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	IronIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Fumigant 93 (D-D)IBA 01/2016
1	Messenger RNA (mRNA)IBA 07/2013

Therapy/Procedure

3	Therapeutics 01/2017 - 01/2013
1	Transcranial Direct Current Stimulation 01/2022